secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001193125-24-268922
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics appoints Gerardo Hernandez as CFO; updates 2024 revenue guidance to $428M-$432M
--------------------------------------------------------------------------------

- Hernandez appointed CFO effective Dec 2, 2024, succeeding Stephen Gordon, who will remain as non-executive employee through Mar 2025 then senior advisor through Mar 2026.
- Hernandez receives $450K base salary, 50% target bonus, and equity awards worth $2M (stock options and RSUs) under the inducement plan.
- 2024 revenue guidance raised to $428-432M, representing 77-79% year-over-year growth.
- Gordon as non-executive employee gets $477K base salary and continues equity vesting; as advisor receives $10K annual fee.
- Hernandez brings 25+ years experience, most recently as VP Finance at Alnylam, and previously at Shire/Takeda.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312524268922/0001193125-24-268922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312524268922/d856128d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-268922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer